000 | 01025 a2200301 4500 | ||
---|---|---|---|
005 | 20250515115757.0 | ||
264 | 0 | _c20080430 | |
008 | 200804s 0 0 eng d | ||
022 | _a1538-3598 | ||
024 | 7 |
_a10.1001/jama.299.16.1949 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPsaty, Bruce M | |
245 | 0 | 0 |
_aFDA guidance on off-label promotion and the state of the literature from sponsors. _h[electronic resource] |
260 |
_bJAMA _cApr 2008 |
||
300 |
_a1949-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aDrug Industry |
650 | 0 | 4 | _aDrug Labeling |
650 | 0 | 4 | _aGuidelines as Topic |
650 | 0 | 4 | _aLegislation, Drug |
650 | 0 | 4 | _aPublishing |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aRay, Wayne | |
773 | 0 |
_tJAMA _gvol. 299 _gno. 16 _gp. 1949-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.299.16.1949 _zAvailable from publisher's website |
999 |
_c17928126 _d17928126 |